Patents by Inventor Qing Du

Qing Du has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12492980
    Abstract: Disclosed are an antibody combination for one-step screening and/or diagnosis of clonal diseases and application thereof. The antibody combination includes eight groups of antibodies, and is a set of flow cytometry detection panels for one-step screening and/or diagnosis of clonal diseases, and 5-tube parallel is used for one sample, the first group of antibodies and the second group of antibodies are used for samples in different flow cytometry tubes, the third group of antibodies and the sixth group of antibodies are used for samples in the same flow cytometry tube, the fourth group of antibodies and the seventh group of antibodies are used for samples in the same flow cytometry tube, and the fifth group of antibodies and the eighth group of antibodies are used for samples in the same flow cytometry tube.
    Type: Grant
    Filed: August 3, 2022
    Date of Patent: December 9, 2025
    Assignees: SYNARC RESEARCH LABORATORY (BEIJING) LTD., HEBEI YANDA LU DAOPEI HOSPITAL
    Inventors: Hui Wang, Man Chen, Aixian Wang, Meiwei Gong, Xueying Wu, Junyi Zhen, Qing Du, Ya Guo
  • Publication number: 20250313735
    Abstract: The present invention provides a dually curable adhesive composition comprising (A) at least one isocyanate-terminated polyurethane prepolymer, (B) at least one radical polymerizable compound, (C) at least one photoinitiator, and (D) at least one moisture curing catalyst, wherein the composition after UV radiation with a wavelength of 375 nm and intensity of 50 mW/cm2 for 60 seconds, has a loss factor value larger than 0.6, as measured at room temperature in accordance with ASTM D4440-15.
    Type: Application
    Filed: June 19, 2025
    Publication date: October 9, 2025
    Inventors: MinRui Li, XiaoKe Zhang, Yongxia Wang, Zhanzheng Qi, Qing Du
  • Patent number: 12146881
    Abstract: The present invention provides a reagent composition for detection of a non-hematopoietic tumor and use thereof. Said reagent composition includes three sets of antibodies, with the first set of antibodies including an anti-CD9 antibody, an anti-GD2 antibody, an anti-CD3 antibody, an anti-CD4 antibody, an anti-CD56 antibody, an anti-CD36 antibody, an anti-CD81, and an anti-CD45 antibody; the second set of antibodies including an anti-HLA-ABC antibody, an anti-CD38 antibody, an anti-CD19 antibody, an anti-CD56 antibody, an anti-CD36 antibody, an anti-CD7 antibody, and an anti-CD45 antibody; the third set of antibodies including anti-cytoplasmic cytokeratin antibodies; wherein the first set of antibodies and the second set of antibodies are respectively used for samples in separate tubes, and the third set of antibodies is used for the sample in the same tube as the second set of antibodies.
    Type: Grant
    Filed: June 14, 2023
    Date of Patent: November 19, 2024
    Assignees: Synarc Research Laboratory (Beijing) Ltd., HEBEI YANDA LUDAOPEI HOSPITAL
    Inventors: Hui Wang, Man Chen, Aixian Wang, Meiwei Gong, Xueying Wu, Junyi Zhen, Qing Du, Ya Guo
  • Patent number: 11966296
    Abstract: A master-slave architecture deployment method based on snapshot includes: restoring a core library corresponding to a MySQL database at any point in snapshot time, where the core library is a virtual library of the MySQL database; querying out at least one piece of configuration information necessary for master-slave configuration of the MySQL database by using the core library as baseline; taking a snapshot on the core library by using a snapshot technology; creating and cloning at least one copy library corresponding to the core library respectively based on the snapshot and the at least one piece of configuration information necessary for master-slave configuration; and configuring a master-slave relationship and a master library and a slave library corresponding to the master-slave relationship for the core library and the at least one copy library. A master-slave architecture deployment device based on snapshot is further provided.
    Type: Grant
    Filed: April 28, 2023
    Date of Patent: April 23, 2024
    Assignee: SHANGHAI SUNINFO INFORMATION TECHNOLOGY CO., LTD.
    Inventors: Zhilong Guang, Fei Chen, Qing Du
  • Patent number: 11953500
    Abstract: The present invention provides a detection reagent and therapeutic target for B cell tumor after targeted therapy and related applications. The reagent composition comprises 3 groups of antibodies, with the first group of antibodies including an anti-CD38 antibody, an anti-CD10 antibody, an anti-CD34 antibody, an anti-CD19 antibody, an anti-CD24 an antibody, an anti-CD20 antibody, an anti-CD81 antibody, an anti-CD45 antibody; the second group of antibodies including an anti-CD38 antibody, an anti-CD10 antibody, an anti-CD34 antibody, an anti-CD19 antibody, an anti-CD20 antibody, an anti-CD72 antibody, an anti-CD45 antibody; and the third group of antibodies including an anti-cytoplasmic CD79a antibody. The reagent composition of the present invention can be applied for the detection of B-lymphocyte tumors after targeted therapy by flow cytometry.
    Type: Grant
    Filed: May 25, 2022
    Date of Patent: April 9, 2024
    Assignees: Synarc Research Laboratory (Beijing) Ltd., HEBEI YANDA LUDAOPEI HOSPITAL
    Inventors: Hui Wang, Man Chen, Aixian Wang, Meiwei Gong, Xueying Wu, Junyi Zhen, Qing Du, Ya Guo
  • Publication number: 20230408524
    Abstract: The present invention provides a reagent composition for detection of a non-hematopoietic tumor and use thereof. Said reagent composition includes three sets of antibodies, with the first set of antibodies including an anti-CD9 antibody, an anti-GD2 antibody, an anti-CD3 antibody, an anti-CD4 antibody, an anti-CD56 antibody, an anti-CD36 antibody, an anti-CD81, and an anti-CD45 antibody; the second set of antibodies including an anti-HLA-ABC antibody, an anti-CD38 antibody, an anti-CD19 antibody, an anti-CD56 antibody, an anti-CD36 antibody, an anti-CD7 antibody, and an anti-CD45 antibody; the third set of antibodies including anti-cytoplasmic cytokeratin antibodies; wherein the first set of antibodies and the second set of antibodies are respectively used for samples in separate tubes, and the third set of antibodies is used for the sample in the same tube as the second set of antibodies.
    Type: Application
    Filed: June 14, 2023
    Publication date: December 21, 2023
    Applicants: Synarc Research Laboratory (Beijing) Ltd., HEBEI YANDA LUDAOPEI HOSPITAL
    Inventors: Hui Wang, Man Chen, Aixian Wang, Meiwei Gong, Xueying Wu, Junyi Zhen, Qing Du, Ya Guo
  • Publication number: 20230267048
    Abstract: A master-slave architecture deployment method based on snapshot includes: restoring a core library corresponding to a MySQL database at any point in snapshot time, where the core library is a virtual library of the MySQL database; querying out at least one piece of configuration information necessary for master-slave configuration of the MySQL database by using the core library as baseline; taking a snapshot on the core library by using a snapshot technology; creating and cloning at least one copy library corresponding to the core library respectively based on the snapshot and the at least one piece of configuration information necessary for master-slave configuration; and configuring a master-slave relationship and a master library and a slave library corresponding to the master-slave relationship for the core library and the at least one copy library. A master-slave architecture deployment device based on snapshot is further provided.
    Type: Application
    Filed: April 28, 2023
    Publication date: August 24, 2023
    Applicant: SHANGHAI SUNINFO INFORMATION TECHNOLOGY CO., LTD.
    Inventors: Zhilong GUANG, Fei CHEN, Qing DU
  • Publication number: 20230074613
    Abstract: Disclosed are an antibody combination for one-step screening and/or diagnosis of clonal diseases and application thereof. The antibody combination includes eight groups of antibodies, and is a set of flow cytometry detection panels for one-step screening and/or diagnosis of clonal diseases, and 5-tube parallel is used for one sample, the first group of antibodies and the second group of antibodies are used for samples in different flow cytometry tubes, the third group of antibodies and the sixth group of antibodies are used for samples in the same flow cytometry tube, the fourth group of antibodies and the seventh group of antibodies are used for samples in the same flow cytometry tube, and the fifth group of antibodies and the eighth group of antibodies are used for samples in the same flow cytometry tube.
    Type: Application
    Filed: August 3, 2022
    Publication date: March 9, 2023
    Applicants: SYNARC RESEARCH LABORATORY (BEIJING) LTD., HEBEI YANDA LU DAOPEI HOSPITAL
    Inventors: Hui WANG, Man CHEN, Aixian WANG, Meiwei GONG, Xueying WU, Junyi ZHEN, Qing DU, Ya GUO
  • Publication number: 20230074660
    Abstract: The present invention provides a detection reagent and therapeutic target for B cell tumor after targeted therapy and related applications. The reagent composition comprises 3 groups of antibodies, with the first group of antibodies including an anti-CD38 antibody, an anti-CD10 antibody, an anti-CD34 antibody, an anti-CD19 antibody, an anti-CD24 an antibody, an anti-CD20 antibody, an anti-CD81 antibody, an anti-CD45 antibody; the second group of antibodies including an anti-CD38 antibody, an anti-CD10 antibody, an anti-CD34 antibody, an anti-CD19 antibody, an anti-CD20 antibody, an anti-CD72 antibody, an anti-CD45 antibody; and the third group of antibodies including an anti-cytoplasmic CD79a antibody. The reagent composition of the present invention can be applied for the detection of B-lymphocyte tumors after targeted therapy by flow cytometry.
    Type: Application
    Filed: May 25, 2022
    Publication date: March 9, 2023
    Applicants: Synarc Research Laboratory (Beijing) Ltd., HEBEI YANDA LUDAOPEI HOSPITAL
    Inventors: Hui WANG, Man CHEN, Aixian WANG, Meiwei GONG, Xueying WU, Junyi ZHEN, Qing DU, Ya GUO
  • Publication number: 20220300760
    Abstract: Systems and methods include determination of a plurality of records, each of the plurality of records including an event, an item, a supplier, and a timestamp, generation, for each of the plurality of records, of a negative sample record including the event of the record, the item of the record, the timestamp of the record, and a sample supplier different from the supplier of the record, association of each of the plurality of records and the generated negative sample records with either a first time period or a second time period based on the timestamp of the record, training of a machine-learning model based on the records and the negative sample records associated with the first time period, and evaluation of the trained model based on the records and the negative sample records associated with the second time period.
    Type: Application
    Filed: March 18, 2021
    Publication date: September 22, 2022
    Inventors: Shruti BHARGAVA, Ran ZHOU, Tanya PIPLANI, Varsha SANKAR, Qing DU, Bharath SIVARAMAN, Fuming WU, KeQiang XIONG
  • Patent number: 11449952
    Abstract: A method of modeling a scenario for use with live data in a production database may include selecting the scenario. The live data can be stored in the production database on a first computing resource, and production scenarios can be stored and executed on the live data using the first computing resource. The method may also include identifying a subset of the live data that are affected by the scenario, copying the subset to a second computing resource to create modeling data, running the scenario on the modeling data using the second computing resource, causing a display device to provide an output comprising a result of the scenario on the modeling data, receiving an input indicating that the scenario is approved, and storing the scenario with the plurality of production scenarios for use on the first computing resource.
    Type: Grant
    Filed: October 1, 2012
    Date of Patent: September 20, 2022
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Chi Ken Yeung, Ravi Shankar, Sondhi, Amira Morcos, Eva Kifri, Dave Altendorf, Qing Du, Hsiaowen Mou, David Bell
  • Patent number: 9208527
    Abstract: A web service for automatically determining accounting entries that are affected by the deletion of a journal, formulating reverse accounting entries, and sending the reverse entries back to the source system is described. The service can use transaction identification keys to map and track which accounting entries are affected by the deletion of the journal. The web service can use extensible markup language (XML) among other formats.
    Type: Grant
    Filed: February 1, 2010
    Date of Patent: December 8, 2015
    Assignee: ORACLE INTERNATIONAL CORPORATION
    Inventors: Wansan Tam, Qing Du, Chi Ken Yeung, Jason Aron Alonzo, Kottresh Kogali, Amarnath Molugu, Simran Sawhney, Arjun Hegde
  • Publication number: 20140095233
    Abstract: A method of modeling a scenario for use with live data in a production database may include selecting the scenario. The live data can be stored in the production database on a first computing resource, and production scenarios can be stored and executed on the live data using the first computing resource. The method may also include identifying a subset of the live data that are affected by the scenario, copying the subset to a second computing resource to create modeling data, running the scenario on the modeling data using the second computing resource, causing a display device to provide an output comprising a result of the scenario on the modeling data, receiving an input indicating that the scenario is approved, and storing the scenario with the plurality of production scenarios for use on the first computing resource.
    Type: Application
    Filed: October 1, 2012
    Publication date: April 3, 2014
    Applicant: ORACLE INTERNATIONAL CORPORATION
    Inventors: CHI KEN YEUNG, RAVI SHANKAR, BHUPINDER SONDHI, AMIRA MORCOS, EVA KIFRI, DAVE ALTENDORF, QING DU, HSIAOWEN MOU, DAVID BELL
  • Patent number: 8645234
    Abstract: A web-service for validating or invalidating accounts from a general ledger (GL) chart of accounts is described. Upon a request from an application for whether an account value corresponding to a department and a product is valid, the service indicates whether the combination of account value/department/product is valid for the chart of accounts. The system can be extensible markup language (XML)-based and can indicate validity down to the line level of a request.
    Type: Grant
    Filed: August 27, 2009
    Date of Patent: February 4, 2014
    Assignee: Oracle International Corporation
    Inventors: Qing Du, Chi Ken Yeung, Wansan Tam, Jason Aron Alonzo
  • Publication number: 20110191214
    Abstract: A web service for automatically determining accounting entries that are affected by the deletion of a journal, formulating reverse accounting entries, and sending the reverse entries back to the source system is described. The service can use transaction identification keys to map and track which accounting entries are affected by the deletion of the journal. The web service can use extensible markup language (XML) among other formats.
    Type: Application
    Filed: February 1, 2010
    Publication date: August 4, 2011
    Applicant: Oracle International Corporation
    Inventors: Wansan Tam, Qing Du, Chi Ken Yeung, Jason Aron Alonzo, Kottresh Kogali, Amarnath Molugu, Simran Sawhney, Arjun Hegde
  • Publication number: 20110055055
    Abstract: A web-service for validating or invalidating accounts from a general ledger (GL) chart of accounts is described. Upon a request from an application for whether an account value corresponding to a department and a product is valid, the service indicates whether the combination of account value/department/product is valid for the chart of accounts. The system can be extensible markup language (XML)-based and can indicate validity down to the line level of a request.
    Type: Application
    Filed: August 27, 2009
    Publication date: March 3, 2011
    Applicant: Oracle International Corporation
    Inventors: Qing Du, Chi Ken Yeung, Wansan Tam, Jason Aron Alonzo